Our recognition
Latest stories
Featured
Hikma delivers strong 2023 performance and a positive outlook for 2024
Press Release, Financial Results
- Inspired at Hikma. Meet Ana Santos Perez Story, Life at Hikma 13 February 2026 Inspired at Hikma. Meet Ana Santos Perez
- Hikma R&D. Innovation in clinical research. Meet Hiba Kamal Story, Life at Hikma 11 February 2026 Hikma R&D. Innovation in clinical research. Meet Hiba Kamal
- Notice of results Press Release, Financial Results 03 February 2026 Notice of results
- Hikma announces launch of Enoby™ (denosumab- qbde) and Xtrenbo™ (denosumab- qbde) referencing Prolia® and Xgeva® respectively Press Release, Product 19 January 2026 Hikma announces launch of Enoby™ (denosumab- qbde) and Xtrenbo™ (denosumab- qbde) referencing Prolia® and Xgeva® respectively
Related content